Fusion protein technologies for biopharmaceuticals applications and challenges /

Shranjeno v:

Bibliografske podrobnosti
Korporativna značnica:	ebrary, Inc
Drugi avtorji:	Schmidt, Stefan R.
Format:	Elektronski eKnjiga
Jezik:	angleščina
Izdano:	Hoboken, N.J. : J. Wiley & Sons, c2013.
Teme:	Recombinant proteins. Biopharmaceutics. Electronic books.
Online dostop:	An electronic book accessible through the World Wide Web; click to view
Oznake:	Označite Brez oznak, prvi označite!

MARC


LEADER	00000nam a2200000 a 4500
001	0000164654
005	20171002063221.0
006	m u
007	cr cn\|\|\|\|\|\|\|\|\|
008	121002s2013 njua sb 001 0 eng d
010			\|z 2012039440
020			\|z 9781118354575 (e-book)
035			\|a (CaPaEBR)ebr10662566
035			\|a (OCoLC)811850420
040			\|a CaPaEBR \|c CaPaEBR
050	1	4	\|a TP248.65.P76 \|b F87 2013eb
082	0	4	\|a 615.7 \|2 23
245	0	0	\|a Fusion protein technologies for biopharmaceuticals \|h [electronic resource] : \|b applications and challenges / \|c edited by Stefan R. Schmidt.
260			\|a Hoboken, N.J. : \|b J. Wiley & Sons, \|c c2013.
300			\|a xxviii, 624 p. : \|b ill.
504			\|a Includes bibliographical references and index.
505	0		\|a pt. 1. Introduction -- pt. 2. The triple t paradigm : time, toxin, targeting -- pt. 3. Beyond the triple t-paradigm.
533			\|a Electronic reproduction. \|b Palo Alto, Calif. : \|c ebrary, \|d 2013. \|n Available via World Wide Web. \|n Access may be limited to ebrary affiliated libraries.
588			\|a Description based on print version record and CIP data provided by publisher; resource not viewed.
650		0	\|a Recombinant proteins.
650		0	\|a Biopharmaceutics.
655		7	\|a Electronic books. \|2 local
700	1		\|a Schmidt, Stefan R.
710	2		\|a ebrary, Inc.
856	4	0	\|u http://site.ebrary.com/lib/daystar/Doc?id=10662566 \|z An electronic book accessible through the World Wide Web; click to view
908			\|a 170314
942	0	0	\|c EB
999			\|c 153800 \|d 153800